Nally Michael
SEC CIK 1763945 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GENB | Generate Biomedicines, Inc. | CEO, Dir | 572.7K | $240.0K | — | 2 | 2026-03-02 | 2026-03-04 |
Most active insiders at GENB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nutritional Health LTP Fund General Partner LLC | 10% | $75.00M | — |
| 2 | Flagship Pioneering Fund VI, L.P. | 10% | $75.00M | — |
| 3 | Nally Michael | CEO, Dir | $240.0K | — |
| 4 | Silvers Jason | Pres, CFO | $32.0K | — |
| 5 | Mendillo Jane L | Dir | $24.0K | — |
| 6 | ARNOLD FRANCES | Dir | — | $16.0K |
| 7 | Grous Beth | CHRO | $4,800 | — |
| 8 | Bancel Stephane | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-06 | 2026-03-04 | GENB | Generate Biomedicines, Inc. | Nally Michael | CEO, Dir | P - Purchase | $12.00 | +20.0K | 572.7K | +4% | +$240.0K | |
| DI | 2026-03-02 | 2026-03-02 | GENB | Generate Biomedicines, Inc. | Nally Michael | CEO, Dir | C - Cnv Deriv | — | +658.3K | 1.32M | +100% | — |
Purchase Sale Sale after option exercise All abbreviations